-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AiQc4BN+XAChU1juWRvcKEe5TVEHPTILrssraqiPazNZnW/kZWAsUBGy6NefpfM0 rIGHqeXWBWXarVFfrtb8IA== 0001011240-02-000054.txt : 20021009 0001011240-02-000054.hdr.sgml : 20021009 20021009122828 ACCESSION NUMBER: 0001011240-02-000054 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20021004 FILED AS OF DATE: 20021009 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: ISAKSON JOHN P CENTRAL INDEX KEY: 0001197402 RELATIONSHIP: DIRECTOR FILING VALUES: FORM TYPE: 3 BUSINESS ADDRESS: STREET 1: 2503 SOUTH HANLEY ROAD CITY: ST LOUIS STATE: MO ZIP: 53144 BUSINESS PHONE: 3146456600 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: KV PHARMACEUTICAL CO /DE/ CENTRAL INDEX KEY: 0000057055 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 430618919 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09601 FILM NUMBER: 02784841 BUSINESS ADDRESS: STREET 1: 2503 S HANLEY RD CITY: ST LOUIS STATE: MO ZIP: 63144 BUSINESS PHONE: 3146456600 MAIL ADDRESS: STREET 1: 2503 S HANLEY RD CITY: ST LOUIS STATE: MO ZIP: 63144 3 1 kvf3isak100802.txt FORM 3 - JOHN P. ISAKSON U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 (Print or Type Responses) ================================================================================ 1. Name and Address of Reporting Person Isakson John P. - -------------------------------------------------------------------------------- (Last) (First) (Middle) 2503 South Hanley Road - -------------------------------------------------------------------------------- (Street) St. Louis MO 63144 - -------------------------------------------------------------------------------- (City) (State) (Zip) ================================================================================ 2. Date of Event Requiring Statement (Month/Day/Year) October 4, 2002 ================================================================================ 3. IRS Identification Number of Reporting Person, if an Entity (Voluntary) ================================================================================ 4. Issuer Name and Ticker or Trading Symbol K-V Pharmaceutical Company (KVA, KVB) ================================================================================ 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) [ X ] Director [ ] 10% Owner [ ] Officer (give title below) [ ] Other (specify below) ================================================================================ 6. If Amendment, Date of Original (Month/Year) ================================================================================ 7. Individual or Joint/Group Reporting (Check Applicable Line) [ X ] Form filed by One Reporting Person [ ] Form filed by More Than One Reporting Person ================================================================================ ================================================================================ Table I -- Non-Derivative Securities Beneficially Owned ================================================================================ 2. 4. Amount of 3. Nature of Securities Ownership Form: Indirect 1. Beneficially Direct (D) or Beneficial Title of Security Owned Indirect (I) Ownership (Instr. 4) (Instr. 4) Instr.5) (Instr. 5) - -------------------------------------------------------------------------------- Class A Common Stock -0- - -------------------------------------------------------------------------------- Class B Common Stock -0- - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- ================================================================================ Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. If the form is filed by more than one reporting persons, see Instruction 5(b)(v) FORM 3 (continued) Table II -- Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) ================================================================================
3. 2. Title and Amount Date of Underlying Exercisable and Derivative 5. Expiration Date Securities 4. Ownership of 6. 1. (Month/Day/Year) (Instr. 4) Conversion Derivative Nature of Title of ---------------- ------------------- or Exercise Security: Indirect Derivative Date Expira- Amount Price of Direct (D) Beneficial Security Exer- tion or Number Derivative Indirect (I) Ownership (Instr. 4) cisable Date Title of Shares Security (Instr. 5) (Instr. 5) - ------------------------------------------------------------------------------------------------------- - ------------------------------------------------------------------------------------------------------- - ------------------------------------------------------------------------------------------------------- - ------------------------------------------------------------------------------------------------------- - ------------------------------------------------------------------------------------------------------- =======================================================================================================
Explanation of Responses: By: /s/ John P. Isakson 10/08/02 --------------------------------------------- ------------------- **Signature of Reporting Person Date ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedures. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a current valid OMB Number. -----END PRIVACY-ENHANCED MESSAGE-----